About Biomed - Company Profile

Biomed Comm,^® Inc. (BMC) is a Seattle-based biotechnology company that is the leader in the field of homeopathic recombinant human growth hormone (HrhGH.) BMC bridges the gap between the effectiveness of prescription recombinant human growth factors and safe, non-toxic over-the-counter (OTC) medicines. BMC’s products support all aspects of “healthy aging,” perhaps the most prevalent health issue among consumers and the media in today’s aging baby boomer population.

BMC differentiates itself from its competitors in that it is science-based, with five U.S. patents, ten clinical studies and eight peer-reviewed papers backing its claims. BMC patented the composition of homeopathic growth hormone and growth factors, as well as treatment methods using these new homeopathic products for strengthening the immune, nervous and hormonal systems. Its founder, CEO and Chief Scientific Officer, Dr. Barbara Brewitt, Ph.D., leads a team of business and scientific professionals in the development, production and marketing of all its products.

BMC developed and patented a new category of over-the-counter (OTC) medicines trademarked Cell Signal Enhancer^® (CSE^®). CSE^® products give people control of their health, optimizing both physiological and psychological health. They combine today’s advanced molecular biotechnology, homeopathic principles and the bioelectric principles of cellular biology to enhance the physical and mental balance in a human body without the toxic side effects and high costs of pharmacological products.

Growth factors are the common language of cell signaling that regulate the body’s functions, including cell growth, nutrient uptake and DNA repair, on a continual basis. Biomed^®, CSE^® products work by stimulating the body’s own defense and healing mechanisms, bringing the body back to its optimal performance level. CSE^® products contain recombinant human growth hormone or growth factors in homeopathic formulations.

Double-blind, placebo controlled clinical studies published in peer-reviewed journals and books show that Biomed Comm’s^® HrhGH patented formula increases lean body mass, improves physical appearance, energy, endurance and boosts immune system functions. Biomed Comm’s^® most popular product, CSE^®-Naturally hGH, has two current patents and is clinically proven to increase energy, endurance, lean body mass, improve physical appearance and reduce body fat.

Biomed Comm^® applies growth factor biotechnology and non-toxic natural medicines to provide health-conscious consumers with a new opportunity to optimize health through easily available, affordable, clinically-proven and safe OTC products. BMC’s other core brand is Jenuv^tm – a topical eye care product which is also clinically proven effective. All BMC formulations are non- animal-derived and are manufactured to the highest standards by authorized FDA and homeopathic approved laboratories using Good Manufacturing Practices. All BMC products are patented in the U.S.A. and internationally.

Founded in 1996, Biomed Comm^® grew from Biomedical Explorations LLC, a company originally formed by Dr. Barbara Brewitt and early investors to fund studies testing efficacy of homeopathic growth factors for treating people infected with HIV. Dr. Brewitt has been heralded for her work in developing a line of professional products that assist health care professionals in treating autistic children, in addition to those products that benefit HIV patients. Her extensive research and intellectual property, including the first clinical studies in the area of homeopathic growth factors and a research grant from the National Institutes of Health (NIH) paved the way for BMC. The company was formed to commercialize products for healthy and chronically symptomatic people.

BMC made its mark by peer review-publishing results from three double blind placebo controlled clinical studies on healthy adults, proving the efficacy of HrhGH as an oral, chewable tablet. The positive clinical results opened the burgeoning market for these scientifically based, efficacious products. Dr. Brewitt published a groundbreaking peer-reviewed article in Alternative and Complementary Therapies in 1999, allowing BMC to strengthen regulatory credibility, build its brand and move forward with new products and additional research. BMC has maintained its position and credibility in the industry through its commitment to establishing solid clinical evidence to back up its claims.

BMC’s mission is to formulate, manufacture, market and widely distribute homeopathic growth factor medicines, in a manner that allows people to self-treat a wide variety of self-recognized symptoms. Baby-boomers are expected to outnumber teenagers by 2050, and 50% of baby boomers are projected to live 100 years. BMC is poised to serve this growing market of people looking for anti-aging products, estimated to be a potential market size of $500 billion within this decade.